Collaboration to Raise Awareness of New Treatment For Rosacea
Allergan plc and Emmy and Tony Award winning actress and singer, Kristin Chenoweth will kick off the “Less Red, More You” campaign at an exclusive event in New York City. As part of the cause, Chenoweth, who suffers from rosacea, will ignite a nationwide conversation about the typically underserved condition while raising awareness for RHOFADE cream, a new product indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.
“As a performer who is constantly on stage or in front of the camera, it’s important that I take care of my skin, but unfortunately, persistent facial redness from rosacea is something I’ve struggled with every day for years,” said Chenoweth. “I’ve been searching for a product that, with daily use, can help keep my redness in check. Recently, my dermatologist recommended something new. She gave me RHOFADE cream. I’m thrilled to partner with Allergan to raise awareness for the persistent facial redness people with rosacea may deal with and RHOFADE cream. I hope that my experience can help make a difference for other sufferers who deal with this challenging condition every day.”
“Kristin is the perfect partner to help us increase awareness about this condition as she understands the daily challenges of living with rosacea,” said Jag Dosanjh, Senior Vice President of Medical Dermatology at Allergan.
In two clinical trials, once daily application of RHOFADE cream was proven to reduce persistent facial erythema associated with rosacea through 12 hours on day 29. Results seen in 12%–18% of people using RHOFADE cream vs 5%–9% of people using vehicle cream.
